Hyperpolarized Carbon-13 MRI for Early Response Assessment of Neoadjuvant Chemotherapy in Breast Cancer Patients.

Hyperpolarized C-MRI is an emerging tool for probing tissue metabolism by measuring C-label exchange between intravenously injected hyperpolarized [1-C]pyruvate and endogenous tissue lactate. Here, we demonstrate that hyperpolarized C-MRI can be used to detect early response to neoadjuvant therapy in breast cancer. Seven patients underwent multiparametric H-MRI and hyperpolarized C-MRI before and 7-11 days after commencing treatment.

MRI-guided breast biopsy: a review of technique, indications, and radiological-pathological correlations.

Breast magnetic resonance imaging (MRI) is the technique of choice in detection, local staging, and monitoring of breast cancer; however, breast MRI results in the detection of more indeterminate/suspicious lesions that need to be histopathologically proven to guide patient management than any other breast imaging method. If such abnormalities are not detectable in any of the conventional imaging tools (mammography (MMG) or ultrasound) then an MRI-guided biopsy needs to be performed to obtain a diagnosis. Breast MRI-guided biopsy is a time-consuming and complex procedure that requires specific equipment and experienced, well-trained staff.